ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
134 | (±¹¿Ü)SCI | How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease |
133 | (±¹¿Ü)SCI | Correspondence:An intradialytic aerobic exercise program ameliorates frailty and improves dialysis adequacy and quality of life among hemodialysis patients: a randomized controlled trial |
132 | (±¹¿Ü)SCI | PTEN induced kinase 1 exerts protective effects in diabetic kidney disease by attenuating mitochondrial dysfunction and necroptosis |
131 | (±¹¿Ü)SCI | Familial focal segmental glomerulosclerosis associated with a WT1 gene missense mutation: a case report |
130 | (±¹¿Ü)SCI | Prostaglandin F2¥á analogue, bimatoprost amelioratescolistin-induced nephrotoxicity |
129 | (±¹¿Ü)SCI | Reassessing the role of the neutrophil-to-lymphocyte ratio in chronic kidney disease patients |
128 | (±¹¿Ü)SCI | Clinical implications of changes in metabolic syndrome status after kidney transplantation: a nationwide prospective cohort study |
127 | (±¹¿Ü)SCI | Machine-learning enhancement of urine dipstick tests for chronic kidney disease detection |
126 | (±¹¿Ü)SCI | Development and validation of urinary exosomal microRNA biomarkers for the diagnosis of acute rejection in kidney transplant recipients |
125 | (±¹¿Ü)SCI | PTEN-induced kinase 1 is associated with renal aging, via the cGAS-STING pathway |
Copyright ¨Ï chamc, All rights reserved.